Create

Sign in to ReadmeX

or

How we handle your data: Privacy Policy

ReadmeX

Your AI reading companion

What would you like to catch up on?

Pick a briefing, or ask your own question.

Your community and people briefings stay personal to you.

Story

Candid Health pilots ElevenAgents for denied insurance claims

AI summary

Candid Health is using ElevenAgents to call insurers and investigate denied insurance claims, according to ElevenLabs. The company says its agents identified both the reason for a denial and the next step in 59% of a 12,860-call pilot, though the report provides no independent evaluation or methodology details.

In-depth insight

The pilot demonstrates a concrete healthcare workflow for voice agents, but its reported performance comes from ElevenLabs and Candid Health without independent validation.

New on our blog: What it takes for a conversational agent to investigate a denied insurance claim.

When a claim is denied, someone usually has to call the insurer to find out why. A single call can take a medical biller anywhere from 10 minutes to an hour. Every payer has its own phone tree, and resolving the call means getting a representative to explain both what went wrong and how to fix it.

Candid Health has been using ElevenAgents to make these calls. Using the speech and turn-taking models we build in-house, their team tuned the agents’ tone and pacing, down to when they pause. In a pilot of 12,860 calls, the agents found both the reason for the denial and the next step in 59% of cases.

“We deliberately set a high bar for success because getting part of the answer doesn’t really help our billers. We needed the agents to handle the entire call, from understanding why a claim was denied to figuring out what to do next. The fact that they could do that in over half of cases, especially this early, exceeded our expectations.” - Doug Proctor, Co-founder and Chief Operating Officer

https://elevenlabs.io/blog/candid-health

#ElevenLabs#ElevenAgents#Candid Health

Original · 1 min readRead the original
Group chat

No comments yet. Start the conversation.